The Src-protein tyrosine kinase Lck is required for IL-1-mediated costimulatory signaling in Th2 cells

被引:22
作者
al-Ramadi, BK
Welte, T
Fernandez-Cabezudo, MJ
Galadari, S
Dittel, B
Fu, XY
Bothwell, ALM
机构
[1] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Med Microbiol, Al Ain, U Arab Emirates
[2] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates
[3] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
D O I
10.4049/jimmunol.167.12.6827
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Src-protein tyrosine kinases are intimately involved in TCR-initiated signaling in T lymphocytes. One member of this family, Lek, is also involved in CD28-mediated costimulation in Th1 cells. In Th2 lymphocytes, the costimulatory signal can also be provided by the interaction of IL-1 with type I IL-1R (IL-IRI), culminating in the activation of NF-kappaB transcription factors. Proximal steps in the IL-1R pathway, however, remain poorly understood, and there is conflicting evidence as to the importance of tyrosine phosphorylation in IL-1R signaling. We have addressed this issue by examining the ability of IL-1 to costimulate the activation of Lek-deficient Th2 cells. Our data demonstrate that, in the absence of Lck, the IL-1 costimulatory pathway is blocked despite the expression of normal levels of IL-1RI. Moreover, the block is associated with a defective degradation of I kappaB-alpha and an incomplete activation of NF-kappaB heterodimeric complexes. Protein expression of NF-kappaB monomers, including p50, p65, and c-Rel, is equivalent in both wild-type and Lck-deficient Th2 cell clones. Finally, we demonstrate that, in normal Th2 cells, stimulation with IL-1 leads to a rapid induction in tyrosine phosphorylation of several substrates including Lek itself. These findings strongly suggest that Lek is required for signaling in the IL-1 costimulatory pathway in Th2 lymphocytes.
引用
收藏
页码:6827 / 6833
页数:7
相关论文
共 40 条
[1]   Cell-cycle arrest and apoptosis hypersusceptibility as a consequence of Lck deficiency in nontransformed T lymphocytes [J].
Al-Ramadi, BK ;
Zhang, H ;
Bothwell, ALM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12498-12503
[2]  
AlRamadi BK, 1996, J IMMUNOL, V157, P4751
[3]  
[Anonymous], ANNU REV IMMUNOL
[4]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[5]   Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation [J].
Béraud, C ;
Henzel, WJ ;
Baeuerle, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :429-434
[6]   Co-stimulation in T cell responses [J].
Chambers, CA ;
Allison, JP .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (03) :396-404
[7]   Advances in cytokine signaling: The role of Jaks and STATs [J].
Chen, E ;
Gadina, M ;
Chen, M ;
O'Shea, JJ .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (03) :1482-1487
[8]   A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B [J].
DiDonato, JA ;
Hayakawa, M ;
Rothwarf, DM ;
Zandi, E ;
Karin, M .
NATURE, 1997, 388 (6642) :548-554
[9]   The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation [J].
Gerondakis, S ;
Grumont, R ;
Rourke, I ;
Grossmann, M .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) :353-359
[10]  
Harhaj EW, 1996, MOL CELL BIOL, V16, P6736